What are the strategic implications for medtech companies as they contemplate the “post-COVID-19” world? L.E.K. Consulting looks at the near-term and longer-term impacts. By Jonas Funk, Monish Rajpal, Ilya Trakhtenberg, and Sheila Shah, L.E.K. Consulting.
There is no doubt that COVID-19 has had a severe impact on the US healthcare ecosystem (as well as the rest of the economy) as providers have focused on managing and caring for COVID-19 patients. The near-term impact, particularly the reduction in elective procedures and physician office visits, has been the focus of major stakeholders in the healthcare ecosystem. Now, as the resumption of physician visits and elective procedures gains traction, the longer-term impacts of COVID-19 are becoming a growing area of focus, given the major changes that will persist even after COVID-19 completes its destructive path.